PA Hollander, L Blonde, R Rowe, AE Mehta, … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS— HbA 1c decreased similarly in the inhaled (−0.7%) and subcutaneous
(−0.6%) insulin groups (adjusted treatment group difference: −0.07%, 95% CI
−0.32 to 0.17). HbA 1c <7.0% was achieved in more patients receiving ... Cited by 237 - Related articles - BL Direct - All 21 versions
- ►annals.org [PDF] J Rosenstock, B Zinman, LJ Murphy, SC … - Annals of internal medicine, 2005 - Am Coll Physicians Inhaled Insulin Improves Glycemic Control When Substituted for or ... Added to
Oral Combination Therapy in Type 2 Diabetes ... Julio Rosenstock, MD; Bernard
Zinman, MD; Liam J. Murphy, MD; Stephen C. Clement, MD; Paul Moore, MD; C. ... Cited by 163 - Related articles - BL Direct - All 8 versions
DR Owens, B Zinman, G Bolli - Diabetic Medicine, 2003 - interscience.wiley.com Attempts at replicating physiological insulin secretion, as a means of restoring
the normal metabolic milieu and thereby minimizing the risk of diabetic
complications, has become an essential feature of insulin treatment. ... Cited by 135 - Related articles - BL Direct - All 5 versions
JE Gerich - Archives of Internal Medicine, 2003 - archinte.highwire.org It is well established that strict glycemic control (hemoglobin A 1c <7.0%) can
prevent the microvascular complications of diabetes mellitus. Recent studies
indicate that elevated plasma glucose concentrations are an independent and ... Cited by 135 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org J Rosenstock, JC Cappelleri, B Bolinder, RA … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Of the 60 patients who received inhaled insulin during the parent
studies, 85.0% (n = 51) chose to continue treatment, 13.3% (n = 8) switched to
subcutaneous insulin, and 1.7% (n = 1) did not continue. Of the 61 patients ... Cited by 132 - Related articles - BL Direct - All 12 versions
- ►diabetesjournals.org K Rave, S Bott, L Heinemann, S Sha, RHA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—INH had a faster onset of action than both RHI and ILP, as indicated
by shorter time to early half-maximal effect (32 vs. 48 and 41 min,
respectively; P < 0.001 for IHN vs. RHI and P < 0.05 for IHN vs. ILP). Time ... Cited by 112 - Related articles - All 7 versions
JS Skyler, RS Weinstock, P Raskin, JF Yale, E … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Mean glycosylated hemoglobin (A1C) decreased comparably from baseline
in the inhaled and subcutaneous insulin groups (−0.3 and −0.1%,
respectively; adjusted difference −0.16% [CI −0.34 to 0.01]), with a ... Cited by 104 - Related articles - BL Direct - All 10 versions
A Himmelmann, J Jendle, A Mellén, AH … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Pharmacokinetic results for evaluable subjects were derived from serum
insulin profiles. The amount of insulin absorbed during the first 6 h after
dosing (area under the exogenous serum insulin curve from 0 to 6 h [AUC ... Cited by 100 - Related articles - BL Direct - All 5 versions
JC Cappelleri, WT Cefalu, J Rosenstock, IA … - Clinical therapeutics, 2002 - Elsevier Methods: This was a 12-week randomized, open-label, parallel-group, controlled
trial in patients with type 2 diabetes. They were randomized to receive either a
subcutaneous insulin regimen (split/mixed insulin with 2 to 3 injections ... Cited by 78 - Related articles - All 5 versions
